NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

I’ve often thought/said the same/similar, but it’s chicken and egg IMO. Let’s take a parallel world from the multiverse where Flaskworks and NWBO were ready to manufacture with an automated closed system technology in 2015. Something tells me the trial statisticians, SAB and regulators would have seen this to trial completion by the end of 2016. Just sayin.

What are we really waiting on now? Imo, more manufacturing progress. I’m not saying they have to get to automated approval of DCVax-l before TLD/publication, but they need to be within a reasonable ramp window, imo.

They don’t need preclinical or clinical biocomparability bridge studies, so unless there’s a hitch, we may be very close.